亚洲社会药学

Objective To study the construction of market credit supervision systems for pharmaceutical enterprises in Liaoning Province and to provide suggestions for improving the integrity awareness and production activities. Methods Based on the market credit supervision experience of National Medical Products Administration and some other provinces, the construction of supervision laws and regulations system for pharmaceutical enterprises in Liaoning Province was investigated from the perspectives of daily supervision and inspection, joint punishment of illegal acts, sampling results, information communication and publicity. Results and Conclusion In recent years, Liaoning Provincial Party Committee and the People’s Government of Liaoning Province has attached great importance to the construction of social credit system by issuing a series of local regulations and local government rules. However, the laws and regulations on the market credit supervision of pharmaceutical enterprises are not perfect, and there is a lack of legal documents such as the credit rating method. Besides, some regulatory documents are slightly outdated and they should be revised in time according to the development of the pharmaceutical industry. The Food and Drug Administration of Liaoning Province should promulgate some relevant laws and regulations on the market credit supervision of pharmaceutical enterprises as soon as possible. Firstly, Liaoning Drug Administration should formulate the “Measures for the Administration of Drug Safety Credit of Pharmaceutical Enterprises”, including the establishment of credit information management system, which can clarify the main responsibility of pharmaceutical enterprises and key personnel, and standardize drug advertising and advertising endorsement. Secondly, Liaoning Drug Administration should introduce the “Credit Rating Methods for Pharmaceutical Enterprises”, and divide the credit rating of pharmaceutical enterprises into four grades from high to low. Besides, differentiated credit supervision measures must be implemented. Finally, the Pharmaceutical Industry Association of Liaoning Province should issue the industry norms that regard drug quality as life so as to improve the integrity awareness of pharmaceutical enterprises and promote the production activities.